HopeStage
Back to all studies
RecruitingNCT04556890

Brain stimulation study for pain and depression

About this titleRead the official source — NCT04556890
Device studyAges 18–75United States
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.

Listed locations
Los AngelesSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 1, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
54
Sponsor
University of California, Los Angeles
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT04556890
Official title
Show the full official title

Multi-target Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Major Depressive Disorder (MDD) and Comorbid Pain

Recruitment & locations

Currently recruiting

Los Angeles

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, Los Angeles, a university.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 75 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies